HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classification

Abstract Purpose To develop an end-to-end convolutional neural network model for analyzing hematoxylin and eosin(H&E)-stained histological images, enhancing the performance and efficiency of nuclear segmentation and classification within the digital pathology workflow. Methods We propose a dual-...

Full description

Saved in:
Bibliographic Details
Main Authors: Junxiao Chen, Ruixue Wang, Wei Dong, Hua He, Shiyong Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Medical Imaging
Subjects:
Online Access:https://doi.org/10.1186/s12880-025-01550-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544200015839232
author Junxiao Chen
Ruixue Wang
Wei Dong
Hua He
Shiyong Wang
author_facet Junxiao Chen
Ruixue Wang
Wei Dong
Hua He
Shiyong Wang
author_sort Junxiao Chen
collection DOAJ
description Abstract Purpose To develop an end-to-end convolutional neural network model for analyzing hematoxylin and eosin(H&E)-stained histological images, enhancing the performance and efficiency of nuclear segmentation and classification within the digital pathology workflow. Methods We propose a dual-mechanism feature pyramid fusion technique that integrates nuclear segmentation and classification tasks to construct the HistoNeXt network model. HistoNeXt utilizes an encoder-decoder architecture, where the encoder, based on the advanced ConvNeXt convolutional framework, efficiently and accurately extracts multi-level abstract features from tissue images. These features are subsequently shared with the decoder. The decoder employs a dual-mechanism architecture: The first branch of the mechanism splits into two parallel paths for nuclear segmentation, producing nuclear pixel (NP) and horizontal and vertical distance (HV) predictions, while the second mechanism branch focuses on type prediction (TP). The NP and HV branches leverage densely connected blocks to facilitate layer-by-layer feature transmission and reuse, while the TP branch employs channel attention to adaptively focus on critical features. Comprehensive data augmentation including morphology-preserving geometric transformations and adaptive H&E channel adjustments was applied. To address class imbalance, type-aware sampling was applied. The model was evaluated on public tissue image datasets including CONSEP, PanNuke, CPM17, and KUMAR. The performance in nuclear segmentation was evaluated using the Dice Similarity Coefficient (DICE), the Aggregated Jaccard Index (AJI) and Panoptic Quality (PQ), and the classification performance was evaluated using F1 scores and category-specific F1 scores. In addition, computational complexity, measured in Giga Floating Point Operations Per Second (GFLOPS), was used as an indicator of resource consumption. Results HistoNeXt demonstrated competitive performance across multiple datasets: achieving a DICE score of 0.874, an AJI of 0.722, and a PQ of 0.689 on the CPM17 dataset; a DICE score of 0.826, an AJI of 0.625, and a PQ of 0.565 on KUMAR; and performance comparable to Transformer-based models, such as CellViT-SAM-H, on PanNuke, with a binary PQ of 0.6794, a multi-class PQ of 0.4940, and an overall F1 score of 0.82. On the CONSEP dataset, it achieved a DICE score of 0.843, an AJI of 0.592, a PQ of 0.532, and an overall classification F1 score of 0.773. Specific F1 scores for various cell types were as follows: 0.653 for malignant or dysplastic epithelial cells, 0.516 for normal epithelial cells, 0.659 for inflammatory cells, and 0.587 for spindle cells. The tiny model’s complexity was 33.7 GFLOPS. Conclusion By integrating novel convolutional technology and employing a pyramid fusion of dual-mechanism characteristics, HistoNeXt enhances both the precision and efficiency of nuclear segmentation and classification. Its low computational complexity makes the model well suited for local deployment in resource-constrained environments, thereby supporting a broad spectrum of clinical and research applications. This represents a significant advance in the application of convolutional neural networks in digital pathology analysis.
format Article
id doaj-art-77b489d760b74254b4d0399e9604855a
institution Kabale University
issn 1471-2342
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Medical Imaging
spelling doaj-art-77b489d760b74254b4d0399e9604855a2025-01-12T12:44:48ZengBMCBMC Medical Imaging1471-23422025-01-0125111610.1186/s12880-025-01550-2HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classificationJunxiao Chen0Ruixue Wang1Wei Dong2Hua He3Shiyong Wang4Department of Information, Third Affiliated Hospital of Naval Medical UniversityDepartment of Neurosurgery, Third Affiliated Hospital of Naval Medical UniversityDepartment of Pathology, Third Affiliated Hospital of Naval Medical UniversityDepartment of Neurosurgery, Third Affiliated Hospital of Naval Medical UniversityDepartment of Information, Third Affiliated Hospital of Naval Medical UniversityAbstract Purpose To develop an end-to-end convolutional neural network model for analyzing hematoxylin and eosin(H&E)-stained histological images, enhancing the performance and efficiency of nuclear segmentation and classification within the digital pathology workflow. Methods We propose a dual-mechanism feature pyramid fusion technique that integrates nuclear segmentation and classification tasks to construct the HistoNeXt network model. HistoNeXt utilizes an encoder-decoder architecture, where the encoder, based on the advanced ConvNeXt convolutional framework, efficiently and accurately extracts multi-level abstract features from tissue images. These features are subsequently shared with the decoder. The decoder employs a dual-mechanism architecture: The first branch of the mechanism splits into two parallel paths for nuclear segmentation, producing nuclear pixel (NP) and horizontal and vertical distance (HV) predictions, while the second mechanism branch focuses on type prediction (TP). The NP and HV branches leverage densely connected blocks to facilitate layer-by-layer feature transmission and reuse, while the TP branch employs channel attention to adaptively focus on critical features. Comprehensive data augmentation including morphology-preserving geometric transformations and adaptive H&E channel adjustments was applied. To address class imbalance, type-aware sampling was applied. The model was evaluated on public tissue image datasets including CONSEP, PanNuke, CPM17, and KUMAR. The performance in nuclear segmentation was evaluated using the Dice Similarity Coefficient (DICE), the Aggregated Jaccard Index (AJI) and Panoptic Quality (PQ), and the classification performance was evaluated using F1 scores and category-specific F1 scores. In addition, computational complexity, measured in Giga Floating Point Operations Per Second (GFLOPS), was used as an indicator of resource consumption. Results HistoNeXt demonstrated competitive performance across multiple datasets: achieving a DICE score of 0.874, an AJI of 0.722, and a PQ of 0.689 on the CPM17 dataset; a DICE score of 0.826, an AJI of 0.625, and a PQ of 0.565 on KUMAR; and performance comparable to Transformer-based models, such as CellViT-SAM-H, on PanNuke, with a binary PQ of 0.6794, a multi-class PQ of 0.4940, and an overall F1 score of 0.82. On the CONSEP dataset, it achieved a DICE score of 0.843, an AJI of 0.592, a PQ of 0.532, and an overall classification F1 score of 0.773. Specific F1 scores for various cell types were as follows: 0.653 for malignant or dysplastic epithelial cells, 0.516 for normal epithelial cells, 0.659 for inflammatory cells, and 0.587 for spindle cells. The tiny model’s complexity was 33.7 GFLOPS. Conclusion By integrating novel convolutional technology and employing a pyramid fusion of dual-mechanism characteristics, HistoNeXt enhances both the precision and efficiency of nuclear segmentation and classification. Its low computational complexity makes the model well suited for local deployment in resource-constrained environments, thereby supporting a broad spectrum of clinical and research applications. This represents a significant advance in the application of convolutional neural networks in digital pathology analysis.https://doi.org/10.1186/s12880-025-01550-2Nuclear segmentationNuclear classificationFeature pyramidConvolutional neural networkDigital pathology
spellingShingle Junxiao Chen
Ruixue Wang
Wei Dong
Hua He
Shiyong Wang
HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classification
BMC Medical Imaging
Nuclear segmentation
Nuclear classification
Feature pyramid
Convolutional neural network
Digital pathology
title HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classification
title_full HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classification
title_fullStr HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classification
title_full_unstemmed HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classification
title_short HistoNeXt: dual-mechanism feature pyramid network for cell nuclear segmentation and classification
title_sort histonext dual mechanism feature pyramid network for cell nuclear segmentation and classification
topic Nuclear segmentation
Nuclear classification
Feature pyramid
Convolutional neural network
Digital pathology
url https://doi.org/10.1186/s12880-025-01550-2
work_keys_str_mv AT junxiaochen histonextdualmechanismfeaturepyramidnetworkforcellnuclearsegmentationandclassification
AT ruixuewang histonextdualmechanismfeaturepyramidnetworkforcellnuclearsegmentationandclassification
AT weidong histonextdualmechanismfeaturepyramidnetworkforcellnuclearsegmentationandclassification
AT huahe histonextdualmechanismfeaturepyramidnetworkforcellnuclearsegmentationandclassification
AT shiyongwang histonextdualmechanismfeaturepyramidnetworkforcellnuclearsegmentationandclassification